MicrobiotiX
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- $17M
Investors
- 13
About MicrobiotiX
Based in Seoul, South Korea, and established in 2016, MICROBIOTIX utilizes safe gastrointestinal microbiota transplant or FMT in a medical environment, to formulate FMT capsules for oral administration, and to research and develop bacteriophages. In 2017, the FMT platform was established, and established a corporate research department in 2018. In 2019, MICROBIOTIX received approval for the bacteriophage clinical research IRB and signed a business agreement with CJ red bio team in 2021. The company develops a treatment for super bacteria with antibiotic resistance by supplying therapeutic agents through intestinal microbes and developing therapeutics through bacteriophages. MICROBIOTIX plans to expand FMT indications for cancer treatment and metabolic diseases through continuous research and system improvement.
Who invested in MicrobiotiX
13 investors across 4 rounds
See all investors in MicrobiotiX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MicrobiotiX
Who invested in MicrobiotiX?
MicrobiotiX has 13 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MicrobiotiX raised?
MicrobiotiX has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did MicrobiotiX last raise money?
MicrobiotiX's most recent round on record is a Series B, in Aug 2025.
What does MicrobiotiX do?
Based in Seoul, South Korea, and established in 2016, MICROBIOTIX utilizes safe gastrointestinal microbiota transplant or FMT in a medical environment, to formulate FMT capsules for oral administration, and to research and develop bacteriophages.
Where is MicrobiotiX headquartered?
MicrobiotiX is headquartered in Seoul, South Korea.
Which VCs invest in companies like MicrobiotiX?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Hengxu Capital and Riverhead Capital back healthcare companies at MicrobiotiX's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like MicrobiotiX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.